Cardiovascular Clinical trialists (CVCT) Workshops have become the authoritative meeting place for cardiovascular trial principal investigators, statisticians, Pharma R&D experts and regulators from the major international agencies. Brainstorming topics included CV drugs, device and biomarker development and trial design, conduct, ethics, interpretation, approvability and implementation. Following the template of the CVCT workshop, the Kidney Disease Clinical Trialists (KDCT) Workshop is a high-level think-tank, with an exceptional expert faculty. It involves a limited number of attendees (70) and includes distinguished nephrologists, clinical trialists, principal investigators and statisticians from academia, R&D pharma and devices , NIH, EMA and FDA.